Showing results (21-30 of 199) with videos related to
Sort By:
Pageof 20
Journal of Neuro-Oncology|February 13, 2010
Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade gliomaRichard M Zuniga, Roy Torcuator, Rajan Jain, et al.Targeted Oncology|September 8, 2010
Targeting integrins in malignant gliomaGhazaleh Tabatabai, Michael Weller, Burt Nabors, et al.Neurosurgery|April 29, 2004
Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosisJack P Rock, Lisa Scarpace, David Hearshen, et al.Journal of Neuro-Oncology|October 28, 2009
Imaging response criteria for recurrent gliomas treated with bevacizumab: role of diffusion weighted imaging as an imaging biomarkerRajan Jain, Lisa M Scarpace, Shehanaz Ellika, et al.Neuro-Oncology|August 30, 2008
Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing diseaseRobert Lustig, Tom Mikkelsen, Glenn Lesser, et al.Journal of Neuro-Oncology|April 10, 2009
Odyssey of hope: a physician's guide to communicating with brain tumor patients across the continuum of careMark L Rosenblum, Steven Kalkanis, Wendy Goldberg, et al.NMR in Biomedicine|May 26, 2017
DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection techniqueAzimeh N V Dehkordi, Alireza Kamali-Asl, Ning Wen, et al.Stem Cells (Dayton, Ohio)|November 26, 2009
Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivoAna C deCarvalho, Kevin Nelson, Nancy Lemke, et al.Molecular & Cellular Proteomics : MCP|June 14, 2005
Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profilesChristine Billecke, Imran Malik, Ashley Movsisyan, et al.Neuro-Oncology|February 11, 2012
Phase I study of terameprocol in patients with recurrent high-grade gliomaStuart A Grossman, Xiaobu Ye, David Peereboom, et al.Pageof 20